bpc 157 what is it benefits risks research Science ACTUALLY Says About This is the first vote

Clinical evidence for topical application includes studies using 50-100 mg/mL solutions with 5-aminolevulinic acid applied daily for 6 months

People frequently associate TB-500 with recovery from muscle strains, soft tissue injuries, and multi-site soreness patterns, though its important to remember that much evidence is not from large-scale human trials

Those seeking deep rejuvenation without needles, downtime, or harsh treatments will appreciate the power of topical copper peptides

It is classified as a triple receptor agonist for its capacity to simultaneously engage the glucose-dependent insulinotropic polypeptide (GIP) receptor, glucagon-like peptide-1 (GLP-1) receptor, and glucagon receptor a receptor profile that differentiates it from the single- and dual-receptor agonists more commonly evaluated in metabolic pharmacology research

PMCID: PMC8996222